These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38781706)

  • 1. Risk of recurrent venous thromboembolism and bleeding in patients with acute isolated subsegmental pulmonary embolism.
    Girardi L; Ciuffini LA; Mai V; Santagata D; Ageno W; Wang TF; Carrier M; Le Gal G
    Thromb Res; 2024 Jul; 239():109037. PubMed ID: 38781706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticoagulation in patients with isolated distal deep vein thrombosis: a meta-analysis.
    Franco L; Giustozzi M; Agnelli G; Becattini C
    J Thromb Haemost; 2017 Jun; 15(6):1142-1154. PubMed ID: 28316124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and effectiveness of oral rivaroxaban versus standard anticoagulation for the treatment of symptomatic deep-vein thrombosis (XALIA): an international, prospective, non-interventional study.
    Ageno W; Mantovani LG; Haas S; Kreutz R; Monje D; Schneider J; van Eickels M; Gebel M; Zell E; Turpie AG
    Lancet Haematol; 2016 Jan; 3(1):e12-21. PubMed ID: 26765643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical course of isolated distal deep vein thrombosis in patients with active cancer: a multicenter cohort study.
    Dentali F; Pegoraro S; Barco S; di Minno MND; Mastroiacovo D; Pomero F; Lodigiani C; Bagna F; Sartori M; Barillari G; Mumoli N; Napolitano M; Passamonti SM; Benedetti R; Ageno W; Di Nisio M
    J Thromb Haemost; 2017 Sep; 15(9):1757-1763. PubMed ID: 28639418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrent venous thromboembolism in patients with pulmonary embolism and right ventricular dysfunction: a post-hoc analysis of the Hokusai-VTE study.
    Brekelmans MP; Ageno W; Beenen LF; Brenner B; Buller HR; Chen CZ; Cohen AT; Grosso MA; Meyer G; Raskob G; Segers A; Vanassche T; Verhamme P; Wells PS; Zhang G; Weitz JI
    Lancet Haematol; 2016 Sep; 3(9):e437-45. PubMed ID: 27570090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Surveillance vs. Anticoagulation For low-risk patiEnts with isolated SubSegmental Pulmonary Embolism: protocol for a multicentre randomised placebo-controlled non-inferiority trial (SAFE-SSPE).
    Baumgartner C; Klok FA; Carrier M; Limacher A; Moor J; Righini M; Beer JH; Peluso M; Rakovic D; Huisman MV; Aujesky D
    BMJ Open; 2020 Nov; 10(11):e040151. PubMed ID: 33444199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of DVT: how long is enough and how do you predict recurrence.
    Agnelli G; Becattini C
    J Thromb Thrombolysis; 2008 Feb; 25(1):37-44. PubMed ID: 17906973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tinzaparin vs Warfarin for Treatment of Acute Venous Thromboembolism in Patients With Active Cancer: A Randomized Clinical Trial.
    Lee AYY; Kamphuisen PW; Meyer G; Bauersachs R; Janas MS; Jarner MF; Khorana AA;
    JAMA; 2015 Aug; 314(7):677-686. PubMed ID: 26284719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants of Late Venous Thromboembolic Events After Acute Isolated Superficial Vein Thrombosis in Daily Practice: 12 Month Results of the INSIGHTS-SVT Study.
    Rabe E; Hoffmann U; Schimke A; Heinken A; Langer F; Noppeney T; Pittrow D; Klotsche J; Gerlach HE; Bauersachs R;
    Eur J Vasc Endovasc Surg; 2023 Nov; 66(5):697-704. PubMed ID: 37573936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term risk of venous thromboembolism recurrence after isolated superficial vein thrombosis.
    Galanaud JP; Sevestre MA; Pernod G; Kahn SR; Genty C; Terrisse H; Brisot D; Gillet JL; Quéré I; Bosson JL
    J Thromb Haemost; 2017 Jun; 15(6):1123-1131. PubMed ID: 28317330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison Between Non-vitamin K Antagonist Oral Anticoagulants and Low-Molecular-Weight Heparin in Asian Individuals With Cancer-Associated Venous Thromboembolism.
    Chen DY; Tseng CN; Hsieh MJ; Lan WC; Chuang CK; Pang ST; Chen SW; Chen TH; Chang SH; Hsieh IC; Chu PH; Wen MS; Chen JS; Chang JW; See LC; Huang WK
    JAMA Netw Open; 2021 Feb; 4(2):e2036304. PubMed ID: 33533929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sub-segmental pulmonary embolism in three academic teaching hospitals: a review of management and outcomes.
    Goy J; Lee J; Levine O; Chaudhry S; Crowther M
    J Thromb Haemost; 2015 Feb; 13(2):214-8. PubMed ID: 25442511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment Patterns and Clinical Outcomes in Korean Cancer Patients With Venous Thromboembolism: A Retrospective Cohort Study.
    Bang SM; Kang JH; Hong MH; Ahn JS; Oh SY; Baek JH; Choi YJ; Shin SH; Kim YJ; Gil HY; Park HE; Lee J; Park EL
    Clin Appl Thromb Hemost; 2021; 27():1076029620979575. PubMed ID: 33471574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic Review and Meta-analysis of Outcomes of Patients With Subsegmental Pulmonary Embolism With and Without Anticoagulation Treatment.
    Bariteau A; Stewart LK; Emmett TW; Kline JA
    Acad Emerg Med; 2018 Jul; 25(7):828-835. PubMed ID: 29498138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients.
    Prandoni P; Noventa F; Ghirarduzzi A; Pengo V; Bernardi E; Pesavento R; Iotti M; Tormene D; Simioni P; Pagnan A
    Haematologica; 2007 Feb; 92(2):199-205. PubMed ID: 17296569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of recurrent venous thromboembolism after acute pulmonary embolism: Role of residual pulmonary obstruction and persistent right ventricular dysfunction. A meta-analysis.
    Becattini C; Giustozzi M; Cerdà P; Cimini LA; Riera-Mestre A; Agnelli G
    J Thromb Haemost; 2019 Aug; 17(8):1217-1228. PubMed ID: 31063646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamics of case-fatalilty rates of recurrent thromboembolism and major bleeding in patients treated for venous thromboembolism.
    Lecumberri R; Alfonso A; Jiménez D; Fernández Capitán C; Prandoni P; Wells PS; Vidal G; Barillari G; Monreal M;
    Thromb Haemost; 2013 Oct; 110(4):834-43. PubMed ID: 23846721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatal Events in Cancer Patients Receiving Anticoagulant Therapy for Venous Thromboembolism.
    Farge D; Trujillo-Santos J; Debourdeau P; Bura-Riviere A; Rodriguez-Beltrán EM; Nieto JA; Peris ML; Zeltser D; Mazzolai L; Hij A; Monreal M;
    Medicine (Baltimore); 2015 Aug; 94(32):e1235. PubMed ID: 26266353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical factors and outcomes of subsegmental pulmonary embolism in cancer patients.
    Yan M; Kieser R; Wu CC; Qiao W; Rojas-Hernandez CM
    Blood Adv; 2021 Feb; 5(4):1050-1058. PubMed ID: 33599740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Venous Thromboembolism Recurrence in Latvian Population: Single University Hospital Data.
    Ģībietis V; Kigitoviča D; Strautmane S; Meilande K; Kalējs VR; Zaičenko A; Maķe K; Lejnieks A; Skride A
    Medicina (Kaunas); 2019 Aug; 55(9):. PubMed ID: 31438542
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.